If you need more lookups,
subscriptions start at $34 USD/month.
Tim Eyes Location
Manchester, England, GB
Tim Eyes Work
Director of Programs, Co-Founder @ (August 2022 - Present)
Research Associate - Synthetic Biology @ (October 2018 - December 2022)
Enterprise Fellow and BBSRC @ (September 2020 - August 2021)
ICURe @ (January 2019 - June 2019)
Research Associate: Biotechnology and Immunology @ (July 2014 - June 2018)
R and D Scientist - Biopharmaceuticals @ (December 2004 - April 2010)
fabMOL - 3D Printed Molecular Models @ (January 2003 - February 2010)
Tim Eyes Education
The University of Manchester
PhD (Biotechnology)
2010-2014
University of Nottingham
MSc (Biotechnology (Distinction))
2003-2004
University of Nottingham
BSc (Biochemistry and Genetics (Hons))
1999-2002
Tim Eyes Skills
ELISA
Protein Structure
Structural Bioinformatics
Surface Plasmon Resonance
Antibodies
Biotechnology
Immunology
Life Sciences
Protein Engineering
Drug Discovery
Molecular Biology
Pharmaceuticals
Bioinformatics
Drug Development
Biacore
X Ray Crystallography
Molecular Modeling
Protein Expression
Protein Purification
Biochemistry
Pharmaceutical Industry
GLP
Flow Cytometry
R&d
Protein Chemistry
Western Blotting
Biopharmaceuticals
Cell Culture
Cell Biology
Assay Development
In Vitro
Polymerase Chain Reaction
Validation
Research
Purification
Biology
Science
High Performance Liquid Chromatography
Genetics
Immunoassays
In Vivo
Inflammation
Biopharmaceutics
Microarray Analysis
CRO Management
R
Tim Eyes Summary
Tim Eyes, based in Manchester, England, GB, is currently a Director of Programs, Co-Founder at Imperagen. Tim Eyes brings experience from previous roles at The University of Manchester, Royal Society of Edinburgh and Innovate UK. Tim Eyes holds a 2010 - 2014 PhD in Biotechnology @ The University of Manchester. With a robust skill set that includes ELISA, Protein Structure, Structural Bioinformatics, Surface Plasmon Resonance, Antibodies and more. Tim Eyes has 2 emails on RocketReach.
Looking for a different Tim Eyes?
Find contact details for 700 million professionals.